AzTrials
AzTrials

Cervical CancerNCT06095882

Randomized Controlled, Open Clinical Study on Efficacy and Safety of Acupuncture for Bladder Function Recovery After Radical Cervical Cancer Surgery

A study testing acupuncture in people with Cervical Cancer, run by Qilu Hospital of Shandong University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Urinary retention is one of the most common complications of radical hysterectomy in patients with cervical cancer, with an incidence of 26-53% depending on the diagnostic criteria. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Cervical Cancer
What is being tested?
acupuncture
Could I receive a placebo?
No, everyone receives an active treatment
How many people
180 participants
Where
No sites listed yet
Study dates
Nov 2023to Nov 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 1) The subjects voluntarily joined the study, signed the informed consent, had good compliance, and cooperated with the follow-up; (2) Female, ≥18 years of age (calculated on the date of signing the informed consent); (3) Pathological diagnosis of cervical cancer, including squamous cell carcinoma, adenocarcinoma and adenosquamous cell carcinoma, preoperative cervical lesions ≤4cm; (4) No history of urinary system infection and urinary retention; (5) Undergoing radical abdominal hysterectomy; (6) On the third day after surgery, vital signs were stable, no discomfort symptoms (such as abnormal abdominal distension, nausea, vomiting, abdominal pain, chest tightness, etc.) of CTCAE 5.0 standard 2 or above, and no abnormal increase in body temperature (≥38.5°C); (7) The function of vital organs meets the following requirements: Absolute neutrophil count ≥1.5×109/L; Platelet ≥100×109/L; Hemoglobin ≥80g/L; Serum albumin ≥2.5g/dL; Bilirubin ≤1.5 ULN; ALT and AST≤3 times ULN; Serum creatinine ≤1.5 ULN; INR≤1.5 or prothrombin time ≤ULN+4 seconds.

Who cannot join

  • Suffering from diseases that may affect bladder function, such as uterine prolapse, vaginal wall bulge, lower urinary tract obstruction, bladder tumor, urethral injury, urinary tract stones, urinary tract infection, spinal cord injury, and sequelae of cardiovascular and cerebrovascular diseases;
  • Poor compliance and failure to strictly carry out full treatment;
  • Use of neostigmine and other drugs that affect bladder function;
  • Patients with serious diseases of important organs and mental diseases;
  • There were random postoperative discomfort symptoms with the severity reaching CTCAE 5.0 level 2 or above;
  • There is an active infection or prerandom unexplained fever ≥38.5°C;
Show all 9Show fewer
  • Patients with clinical symptoms or diseases of heart that are not well controlled, such as: NYHA2 or above heart failure, unstable angina pectoris, myocardial infarction within 1 year, clinically significant supraventricular or ventricular arrhythmia requiring treatment or intervention;
  • diabetic patients;
  • In the judgment of the investigator, the subjects have other factors that may lead to the forced termination of the study, such as other serious diseases (including mental illness) requiring combined treatment, serious abnormalities in laboratory tests, and family or social factors that may affect the safety of the subjects or the collection of data.

Trial locations and contacts

No sites are listed yet.

Hualei Bu contact

buhualei@email.sdu.edu.cn

About this study

Urinary retention is one of the most common complications of radical hysterectomy in patients with cervical cancer, with an incidence of 26-53% depending on the diagnostic criteria.

The most common method to prevent urinary retention after radical hysterectomy is continuous catheterization, but up to 14.5% of patients need continuous catheterization for more than 4 weeks, because catheterization is an invasive procedure, increasing the risk of urinary tract infection, and long-term postoperative retention of urinary catheter caused by edema of the vesicourethral sphincter and urethral glands. Obstruction of bladder outlet caused by increased urethral outflow resistance may also lead to postoperative urinary retention, thus forming a vicious cycle and aggravating urinary retention.

In our previous retrospective analysis, it was confirmed that acupuncture and moxibustion were effective in restoring bladder function after radical hysterectomy. Compared with the control group, the incidence of urinary retention in patients receiving acupuncture and moxibustion was reduced from 44.17% to 24.17%, and no serious adverse reactions occurred, and the patients had good tolerance. We plan to conduct further randomized controlled studies to confirm this.

Read the detailed description
  1. Basis for project establishment Cervical cancer is a deadly gynecological malignancy, with about 98,900 new cases and 30,500 deaths every year in China, and the age of onset is decreasing[1]. According to the 2022 NCCN guidelines, radical hysterectomy combined with pelvic lymphadenectomy is the standard surgical protocol for early cervical cancer, however, 30-85% of patients experience bladder dysfunction after radical hysterectomy, with negative effects on postoperative recovery and the patient's quality of life [2-4]. Urinary retention is one of the most common complications of radical hysterectomy, with an incidence of 26-53% according to different diagnostic criteria [5-7], mainly due to bladder paralysis or dysfunction caused by amputation or injury of the bladder autonomic nerve, extensive excision of the sacral ligament, the major ligament, and the vagina [8-10]. In recent years, nerve sparing radical hysterectomy has received widespread attention, but due to the complex anatomy of the pelvic nerve, the difficulty of the operation, and more importantly, the incomplete resection of the tumor, this surgery has not been widely used in clinical practices[11]. Currently, the most commonly used method to prevent urinary retention after radical hysterectomy is continuous catheterization, but up to 14.5% of patients require continuous catheterization for more than 4 weeks, due to the invasive procedure, increasing the risk of urinary tract infection[12], and long-term postoperative indwelling of urinary tubes caused by vesicourethral sphincter and urethral gland edema. Obstruction of bladder outlet caused by increased urethral outflow resistance may also lead to postoperative urinary retention. This creates a vicious cycle that exacerbates urinary retention [13]. Therefore, the use of effective treatment means to strengthen the contraction ability of the detrusor muscle of the bladder and reduce spasm of the external urethral sphincter can help improve the bladder function impairment caused by surgery, restore the bladder urination function, reduce the pain of resetting the urinary tube and the probability of urinary system infection, and improve the quality of life of patients. For this reason, scholars have conducted some studies. Such as sacral neuromodulation [14,15] and drug therapy [16,17], however, have not achieved a very significant therapeutic effect. Therefore, it is necessary for us to further explore a better treatment to solve this clinical challenge. Acupuncture and moxibustion is an ancient treatment method originated in ancient China, which can be used to treat postoperative urinary retention from thousands of years of literature records and clinical practice. Previous studies have also confirmed its partial effect on urinary retention, [18-20], increasing the success rate of urinary tube removal, reducing the length of hospital stay, and alleviating patients' pain. In traditional Chinese medicine, urine retention after surgery is classified into the category of "retention of urine". The disease is located in the bladder, which is closely related to lung, spleen, kidney and three jiao. It is believed that the main mechanism of its occurrence is the injury of Chongren and other veins and the deficiency of qi and blood. Kidney deficiency leads to gasified disorganization and unfavorable bladder opening and closing. Spleen deficiency and dereliction of duty, water is not wet, eventually resulting in poor urine, urine retention. Through the previous study of modern acupuncture and moxibustion literature, we found that the common acupoints for preventing and treating urinary retention were mainly concentrated in the lower extremities, lower abdomen and lumbsacral area [21,22], such as Ciliao, Yinlingquan and Sanyinjiao, and the curative effect of Yinlingquan was superior to Sanyinjiao [23]. In our previous retrospective analysis, it was also confirmed that acupuncture was effective in restoring bladder function after radical hysterectomy. Compared with the control group, the incidence of urinary retention in patients receiving acupuncture was reduced from 44.17% to 24.17%, and no serious adverse reactions occurred, and the patient tolerance was good. In order to objectively observe the clinical therapeutic effect of acupuncture on the recovery of bladder function in patients after radical hysterectomy, we plan to further carry out randomized controlled studies to confirm, and analyze the characteristics and spatial distribution of tenderness sensitization, explore the correlation law of acupoint-zang-organ/body, and evaluate the specific connection difference between different acupoints and internal organs, so as to provide objective basis for clinical selection of acupoints.
  2. Test purpose 2.1 Main research objectives: To evaluate the efficacy and safety of acupuncture for bladder function recovery after radical cervical cancer surgery by comparing the residual urine volume after catheter removal 14 days after surgery.

2.2 Secondary research purposes and exploratory research purposes:

  1. To explore the characteristics and spatial distribution of acupoint tenderness sensitization of patients after radical cervical cancer surgery;
  2. Explore the relevant laws of acupoint-zang-fu/body;
  3. To explore the correlation between the occurrence of urinary retention and related clinicopathological features;
  4. To explore the influence of acupuncture treatment on the prognosis of patients. 3. Pilot plan 3.1 Experimental design The objective of this study was to evaluate the residual urine volume of catheter removal 14 days after radical hysterectomy in patients with cervical cancer, and to evaluate the efficacy and safety of acupuncture for bladder function recovery after radical hysterectomy for cervical cancer.

A total of 180 patients with preoperative cervical lesions ≤4cm were randomly assigned to the observation group and acupuncture treatment group according to 1:1. The patients in the study group received acupuncture treatment from the 3rd day after surgery to the 14th day after surgery. The acupuncture points included Zhongwan, Tianshu, Shuitshui, Taichong, Sanyinjiao, Zusanli and Yin Lingquan. The control group had no intervention measures, and the urinary tube was removed on the 14th day after surgery. The control group patients with urinary retention could receive further acupuncture treatment.

The study was divided into screening period, treatment period and follow-up period.

Conditions
Cervical Cancer
Being tested
acupuncture
Medical subject headings
Uterine Cervical Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • acupunctureOther

    Study group: Acupuncture treatment was performed from day 3 to day 14 after surgery. Points include: Zhongwan, Tianshu, Watercourse, Taichong, Sanyinjiao, Zusanli, Yin Lingquan.

    Control group: No intervention, the urinary tube was removed until the 14th day after surgery. Patients with urinary retention may receive further acupuncture treatment.

Study groups in NCT06095882
Study groupRoleWhat they receive
acupunctureExperimentalNot described
Receives: Other: acupuncture
observeNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The incidence of urinary retention

    The urinary tube was removed 14 days after operation and the residual urine volume was measured

    Measured: 1year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Oct 2023
  2. Study startNov 2023 (estimated)
  3. Primary completionDec 2024 (estimated)
  4. Study completionNov 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Masking
Single blind
Who is masked
Participant
Enrolment
180 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06095882
Sponsor's protocol ID
KYLL-202309-002
Status last verified
Sep 2023
First submitted
16 Oct 2023
Last updated
23 Oct 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing acupuncture in people with Cervical Cancer, run by Qilu Hospital of Shandong University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 23 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Hualei Bu (buhualei@email.sdu.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The incidence of urinary retention (time frame: 1year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Oct 2023; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in